159 related articles for article (PubMed ID: 36748984)
1. Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism.
Tlili G; Mesguich C; Gaye D; Tabarin A; Haissaguerre M; Hindié E
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):114-121. PubMed ID: 36748984
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of Cervical Ultrasound,
Boudousq V; Guignard N; Gilly O; Chambert B; Mamou A; Moranne O; Zemmour M; Sharara H; Lallemant B
J Nucl Med; 2022 Jul; 63(7):1081-1086. PubMed ID: 34857659
[TBL] [Abstract][Full Text] [Related]
3. Primary Hyperparathyroidism: Defining the Appropriate Preoperative Imaging Algorithm.
Hindié E; Schwartz P; Avram AM; Imperiale A; Sebag F; Taïeb D
J Nucl Med; 2021 Jul; 62(Suppl 2):3S-12S. PubMed ID: 34230072
[TBL] [Abstract][Full Text] [Related]
4. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
Chen YH; Chen HT; Lee MC; Liu SH; Wang LY; Lue KH; Chan SC
Ann Nucl Med; 2020 Aug; 34(8):527-537. PubMed ID: 32436180
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.
Michaud L; Balogova S; Burgess A; Ohnona J; Huchet V; Kerrou K; Lefèvre M; Tassart M; Montravers F; Périé S; Talbot JN
Medicine (Baltimore); 2015 Oct; 94(41):e1701. PubMed ID: 26469908
[TBL] [Abstract][Full Text] [Related]
6.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
7. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
Kluijfhout WP; Vorselaars WM; Vriens MR; Borel Rinkes IH; Valk GD; de Keizer B
Eur J Radiol; 2015 Sep; 84(9):1745-51. PubMed ID: 26047823
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Neck Ultrasonography, Dual Phase
Abhishek B; Wakankar R; Dharmashaktu Y; Damle NA; Kumar P; Bal C; Tripathi M; Kandasamy D; Khadgawat R; Agarwal S; Vuthaluru S; Chumber S
Indian J Nucl Med; 2023; 38(3):208-217. PubMed ID: 38046978
[TBL] [Abstract][Full Text] [Related]
9. Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patients.
Morland D; Lalire P; Deguelte S; Zalzali M; Richard C; Dejust S; Boulagnon C; Ly S; Papathanassiou D; Delemer B
Medicine (Baltimore); 2020 Jan; 99(2):e18681. PubMed ID: 31914064
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism.
Dudoignon D; Delbot T; Cottereau AS; Dechmi A; Bienvenu M; Koumakis E; Cormier C; Gaujoux S; Groussin L; Cochand-Priollet B; Clerc J; Wartski M
Diagn Interv Imaging; 2022 May; 103(5):258-265. PubMed ID: 35039246
[TBL] [Abstract][Full Text] [Related]
11. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
Schalin-Jäntti C; Ryhänen E; Heiskanen I; Seppänen M; Arola J; Schildt J; Väisänen M; Nelimarkka L; Lisinen I; Aalto V; Nuutila P; Välimäki MJ
J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.
Caveny SA; Klingensmith WC; Martin WE; Sage-El A; McIntyre RC; Raeburn C; Wolfe P
J Nucl Med Technol; 2012 Jun; 40(2):104-10. PubMed ID: 22566587
[TBL] [Abstract][Full Text] [Related]
13.
Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
[TBL] [Abstract][Full Text] [Related]
14.
Christakis I; Khan S; Sadler GP; Gleeson FV; Bradley KM; Mihai R
Ann R Coll Surg Engl; 2019 Sep; 101(7):501-507. PubMed ID: 31305126
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.
Lezaic L; Rep S; Sever MJ; Kocjan T; Hocevar M; Fettich J
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2083-9. PubMed ID: 25063039
[TBL] [Abstract][Full Text] [Related]
16. Value of
Asseeva P; Paladino NC; Guerin C; Castinetti F; Vaillant-Lombard J; Abdullah AE; Farman-Ara B; Loundou A; Sebag F; Taïeb D
Am J Surg; 2019 Jan; 217(1):108-113. PubMed ID: 29980283
[TBL] [Abstract][Full Text] [Related]
17. Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery.
Rubello D; Massaro A; Cittadin S; Rampin L; Al-Nahhas A; Boni G; Mariani G; Pelizzo MR
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1091-4. PubMed ID: 16804688
[TBL] [Abstract][Full Text] [Related]
18. Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.
Quak E; Lasne Cardon A; Ciappuccini R; Lasnon C; Bastit V; Le Henaff V; Lireux B; Foucras G; Jaudet C; Berchi C; Grellard JM; Lequesne J; Clarisse B; Bardet S
BMC Endocr Disord; 2021 Jan; 21(1):3. PubMed ID: 33413316
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive (99m)Tc-sestamibi radioguided surgery of parathyroid adenomas.
Rubello D; Giannini S; De Carlo E; Mariani G; Muzzio PC; Rampin L; Pelizzo MR
Panminerva Med; 2005 Jun; 47(2):99-107. PubMed ID: 16210995
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of 99mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
Mandic A; Kraljevic I; Skoric Polovina T; Zibar Tomsic K; Dusek T; Balasko A; Solak M; Kastelan D
Exp Clin Endocrinol Diabetes; 2024 Apr; 132(4):216-220. PubMed ID: 38320618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
